<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:department>Unknown</gtr:department><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3545CDC8-076D-4BD8-B370-8E558F9D46EE"><gtr:id>3545CDC8-076D-4BD8-B370-8E558F9D46EE</gtr:id><gtr:name>Leeds Teaching Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Beckett Street</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS9 7TF</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0A8A4ACA-0127-4830-90EE-CFF49156C062"><gtr:id>0A8A4ACA-0127-4830-90EE-CFF49156C062</gtr:id><gtr:firstName>Eldo</gtr:firstName><gtr:otherNames>Thomas</gtr:otherNames><gtr:surname>Verghese</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0902032"><gtr:id>C38A067F-EDE5-42B6-8AF7-038EA13845D1</gtr:id><gtr:title>MicroRNAs and stromal-epithelial cell signalling during carcinogenesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0902032</gtr:grantReference><gtr:abstractText>Alterations in the levels of certain proteins within a cell changes a normal epithelial cell into a malignant cancer cell. Similar changes also occur in the cells adjacent to these cancer cells - the stromal fibroblasts. These fibroblasts influence the behaviour of the cancer cells, and thereby influence cancer outcome.

MicroRNAs are molecules that control the amounts of certain proteins. The microRNAs within normal and cancer epithelial cells are different, and are responsible - in part - for the process of becoming a cancer. My hypothesis is that the microRNAs within fibroblast cells are different in normal tissue and cancer tissue. I propose to study the fibroblast microRNAs, and to examine their role in controlling the behaviour of cancers. This may eventually help in prediction of likely survival from individual cancers and in development of novel cancer treatments targeted against these pathways.</gtr:abstractText><gtr:technicalSummary>Background 
During carcinogenesis, epithelial cells and adjacent stromal fibroblasts both exhibit changes in gene expression. Molecular pathways responsible for these changes are better researched and understood in epithelial cells than in fibroblasts, despite the fact that fibroblasts adjacent to carcinoma cells (carcinoma-associated fibroblasts, CAFs) have important influences on cancer behaviour. MicroRNAs are newly discovered regulators of gene expression, which have roles in the control of proliferation and apoptosis. Importantly, critical roles for microRNAs as tumour-suppressor genes and oncogenes have been identified in the epithelial cells of many cancers. Potential analogous roles for microRNAs within stromal fibroblasts during carcinogenesis remain un-explored.
 
Aims
I will elucidate microRNA-dependent molecular pathways that control stromal-epithelial cell signalling. These pathways are currently poorly understood and insights may lead to new therapeutic opportunities.
 
Methodology
I will identify microRNAs whose expression within fibroblasts is altered during carcinogenesis. I have micro-dissect normal fibroblasts (NFs) and CAFs from a case of breast cancers and determined microRNA expression patterns using microarrays. Similarly, I identified such microRNAs in a tissue culture model in which immortalised breast fibroblasts were cultured either alone (model for NFs) or co-cultured with a breast carcinoma cell line (model for CAFs). MicroRNAs that showed consistent changes in expression between NFs and CAFs in the tissue study and from the tissue culture model were selected. Expression of 10 microRNAs (selected because of &amp;gt;10 fold change or their evidence in literature for a role in cancer/fibroblast function), were examined initially using q-PCR. 4 miRNA have been identified as being consistently down-regulated in all the samples examined. These miRNA(miR-30b, miR-23b, miR-10a, let-7g) will be further examined using qPCR in further clinical samples. This expression will also be confirmed using ISH in a large panel of matched clinical NFs and CAFs from breast cancers. 

Having demonstrated consistent expression changes for some microRNAs, I will examine their functional roles. I will identify their predicted targets using bioinformatics tools and will develop experimental approaches to modify microRNA expression, thereby working to validate these targets. Finally, I will investigate roles of these miRNAs in fibroblasts in controlling, first, behaviour of the fibroblasts themselves, and, secondly, in regulating influences of fibroblasts on epithelial cancer cells. 

Scientific and Medical Opportunities
This study will add to the growing evidence for the importance of stromal fibroblasts in cancer biology as well as giving new insights into roles for microRNAs in epithelial:stromal interactions. MicroRNAs identified could have roles as prognostic/predictive factors. Furthermore, these microRNA and the molecules they regulate could serve as targets for developing newer treatments directed at the stromal compartment of cancers.</gtr:technicalSummary><gtr:fund><gtr:end>2013-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>212055</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Identification of marker that could predict bone metastasis in breast canecr</gtr:description><gtr:id>63BA5304-4E31-4DA7-8C68-81CCACB5A6F7</gtr:id><gtr:impact>Nil</gtr:impact><gtr:outcomeId>DpdyhYR2P7E-1</gtr:outcomeId><gtr:partnerContribution>Running of the Azure trial</gtr:partnerContribution><gtr:piContribution>Analysis of CDH11 in subset of patients with breast tumours from the AZURE trial</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>91000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Path Soc Career Development Fellowship</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Alzheimer?s Society</gtr:fundingOrg><gtr:id>85087542-6698-40FF-8062-F822DC4FBB0C</gtr:id><gtr:outcomeId>5460d4811a83d3.60194010</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Examination miRNA in the stroma using ISH has shown that some of the more common miRNA that were thought to upregulated are in fact upregulated in the stroma as opposed to the epithelial compartment of breast cancer tissue</gtr:description><gtr:id>B2077CE3-9736-42C5-BC67-F528E5B565F9</gtr:id><gtr:impact>It role of these miRNA is currently being investigated</gtr:impact><gtr:outcomeId>EVvmtofFyFG</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ISH</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C65DA974-231D-4A28-B059-7D8F0420C432</gtr:id><gtr:title>Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast Carcinogenesis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d800fe2353c2fd435d4e9f68af2a0c5d"><gtr:id>d800fe2353c2fd435d4e9f68af2a0c5d</gtr:id><gtr:otherNames>Smith L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>585d56ec8bc4a1.51752376</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02D4BE21-65BC-4347-88A3-1A0DB4387F12</gtr:id><gtr:title>Neoadjuvant chemotherapy induces expression levels of breast cancer resistance protein that predict disease-free survival in breast cancer.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2ba0b6d46aa315a82b74768e5ca8960"><gtr:id>c2ba0b6d46aa315a82b74768e5ca8960</gtr:id><gtr:otherNames>Kim B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_55f945294521c6334</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7103F7E-F866-443F-ACEC-81258486760B</gtr:id><gtr:title>MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34bd70363109b2d1e45983a7d37ef56d"><gtr:id>34bd70363109b2d1e45983a7d37ef56d</gtr:id><gtr:otherNames>Verghese ET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>pm_13400_20_23939832</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9DE8FC2-4334-4C7D-B223-F0B3DA05BA06</gtr:id><gtr:title>PSMD9 expression predicts radiotherapy response in breast cancer.</gtr:title><gtr:parentPublicationTitle>Molecular cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e28c420ac042452d56e08169a01ac01d"><gtr:id>e28c420ac042452d56e08169a01ac01d</gtr:id><gtr:otherNames>Langlands FE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1476-4598</gtr:issn><gtr:outcomeId>doi_55f9459452122478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87CB2F85-4DA8-4274-9BE1-E7EE1E3CA588</gtr:id><gtr:title>The value of archival tissue blocks in understanding breast cancer biology.</gtr:title><gtr:parentPublicationTitle>Journal of clinical pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03f38d1fc62e96aa2c959091aebb20b1"><gtr:id>03f38d1fc62e96aa2c959091aebb20b1</gtr:id><gtr:otherNames>Dowsett T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9746</gtr:issn><gtr:outcomeId>pm_540e16fe16f6cb8c3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>449DA5A2-EE30-475D-A399-F96CBF14B1C3</gtr:id><gtr:title>Small is beautiful: microRNAs and breast cancer-where are we now?</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34bd70363109b2d1e45983a7d37ef56d"><gtr:id>34bd70363109b2d1e45983a7d37ef56d</gtr:id><gtr:otherNames>Verghese ET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>pm_13400_10_18446835</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>126F0BF5-DF5E-484E-BD60-4FDF4782C6F5</gtr:id><gtr:title>The roles of microRNAs in sarcomas.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34e6288bd089a499325a6146e96b710e"><gtr:id>34e6288bd089a499325a6146e96b710e</gtr:id><gtr:otherNames>Drury R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>pm_13400_20_22488672</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0902032</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>